-
GUILDFORD, UNITED KINGDOM - Feb 27, 2019 - MR Solutions latest compact preclinical, multi-modality MRI systems will be on display at the 14th European Molecular Imaging Meeting (EMIM 2019) being held at the Scottish Event Campus in Glasgow on 19 to 22 March, 2019
Feb 27, 2019
-
LOS ANGELES, CA, UNITED STATES - Feb 21, 2019 - https://globenewswire.com/news-release/2019/02/21/1739290/0/en/AlloSure-now-available-for-Lung-Transplant-Patients
Feb 21, 2019
-
PRINCETON, NJ - Feb 21, 2019 - Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, today announced the launch of version 19
Feb 21, 2019
-
GLASGOW, UK - Feb 12, 2019 - SAW Diagnostics Limited (SAW Dx), an emerging biological sample analysis and point of care diagnostic company, announced today that Innovate UK, the UKs innovation Agency, has awarded the company a £1
Feb 19, 2019
-
CAMBRIDGE, MA, US - Feb 19, 2019 - Shimmer, a global leader in wearable technology for research applications, today announced the launch of Verisense, its next-generation wearable sensor platform designed from the ground up to meet the needs of clinical trial sponsors, sites and participants
Feb 19, 2019
-
HERCULES, CA - Feb 14, 2019 - (BUSINESS WIRE) - Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rads Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industrys first digital PCR products to receive U
Feb 15, 2019
-
CHICAGO, IL, UNITED STATES - Feb 10, 2019 - Sysmex America, Inc., a leading diagnostic solutions company offering hematology, urinalysis and flow cytometry testing technology that improves clinical laboratory performance, announced the availability of its first fully automated urine particle counter and digital imaging system, the UN-2000
Feb 10, 2019
-
PRINCETON, NJ - Feb 7, 2019 - Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, today announced its latest advances in bringing model-informed precision dosing (MIPD) to the point of care
Feb 7, 2019
-
LONDON, UNITED KINGDOM - Feb 7, 2019 -
Leading healthcare technology investors partner with Clinithink to unlock the potential of unstructured data to inform treatment decisions, identify candidates for clinical trials, and ensure appropriate reimbursement
Clinithink,
which
offers healthcare and life sciences organizations powerful clinical data insights through its patented CLiX natural language processing (NLP) platform, has secured a growth-equity investment from TT Capital Partners (TTCP) and the MSD Global Health Innovation Fund (GHI) to expand its global footprint and continue to broaden its service offering
Feb 7, 2019
-
PRINCETON, NJ - Jan 30, 2019 - The WIRB-Copernicus Group®s (WCG) Market Intelligence & Insights Division has acquired First Clinical Research LLC, organizer of the MAGI (Model Agreements & Guidelines International) Clinical Research Conference, which unifies the clinical research ecosystem by facilitating communication and the sharing of best practices among members
Jan 30, 2019
-
PRINCETON, NJ - Jan 29, 2019 - Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, today announced the launch of version 18 of its Simcyp® Population-based Simulator
Jan 29, 2019
-
CAMBRIDGE, UK - Jan 18, 2019 - ~~Rapid Biosensor Systems (RBS), the technology company that developed a 2-minute breathalyser test for TB, can adapt its platform technology for screening of lung cancer
Jan 18, 2019
-
PRINCETON, NJ - Jan 15, 2019 - Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, today reported that more than 90% of novel new drug approvals by the US Food and Drug Administration (FDA) in 2018 were supported by Certara software or services
Jan 15, 2019
-
SAN ANTONIO, TX, UNITED STATES - Jan 8, 2019 - SAN ANTONIO, Jan. 8, 2019 /PRNewswire/ -- Seno Medical Instruments, Inc. (Seno Medical), the leader in new technology for breast cancer diagnosis using opto-acoustic ultrasound (OA/US) imaging to differentiate benign from malignant masses, today provided a summary of key 2018 data publications and presentations that demonstrate the clinical utility and healthcare economic benefits of its proprietary, cutting-edge technology
Jan 8, 2019
-
BRISBANE, CA, UNITED STATES - Dec 20, 2018 - BRISBANE, Calif., Dec. 20, 2018 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions for transplant patients, today announces the publication of data demonstrating the clinical utility of measuring AlloSure in repeat kidney transplant recipients in the
American Journal of Transplantation
Dec 20, 2018
-
SUFFERN, NY, UNITED STATES - Dec 20, 2018 - SUFFERN, N.Y., Dec. 20, 2018 (GLOBE NEWSWIRE) -- CDx Diagnostics today announced the publication of new data demonstrating that the addition of WATS3D (Wide Area Transepithelial Sampling with 3D Tissue Analysis) to standard targeted and random forceps biopsy (FB) markedly increases the overall detection of esophageal dysplasia (ED) by 242% and the overall detection of Barretts esophagus (BE) by 153% in patients undergoing BE screening and surveillance
Dec 20, 2018
-
PRINCETON, NJ - Dec 19, 2018 - Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access, today announced a new research report that investigates the potential of pharmaceutical outcomes-based contracting
Dec 19, 2018
-
ALAMEDA, CA, UNITED STATES OF AMERICA - Dec 17, 2018 - Contact: Marcia Ruggio
Global Brand Marketing Manager
m.ruggio@singulex.com
(510) 995-3859Singulex, Inc
Dec 17, 2018
-
, UK & INDIA - Dec 12, 2018 - QuantuMDx Group Limited and Molbio Diagnostics Private Limited have signed a memorandum of understanding (MoU) to explore opportunities for joint working in infectious disease diagnostics, with an initial focus on genotypic drug resistance testing for those infected with tuberculosis
Dec 12, 2018
-
SYDNEY, AUSTRALIA - Dec 10, 2018 - AusDiagnostics has CE marked a new kit for detection of haemochromatosis - a genetic disease that results in iron overload and eventually organ failure
Dec 9, 2018